Samsung and Mass General Hospital Partner to Study GLP-1 Monitoring via Galaxy Watch

The New Frontier of GLP-1 Treatment Monitoring As the popularity of GLP-1 receptor agonists (GLP-1RAs) surges—with nearly one in five U.S. Adults reporting usage—the medical community is shifting its focus from simple weight loss to sustainable, long-term health. A primary concern for clinicians is the unintended loss of muscle mass during rapid weight reduction, which … Read more